OXYBUTYNIN

OXYBUTYNIN was reported 29395 times

OXYBUTYNIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 50 0.1650
1 PRODUCT CLOSURE REMOVAL DIFFICULT 71 0.0696
2 ANTICHOLINERGIC SYNDROME 72 0.0452
3 APPLICATION SITE ERYTHEMA 932 0.0355
4 HYPERTONIC BLADDER 102 0.0353
5 BLADDER SPASM 59 0.0315
6 FEMALE GENITAL TRACT FISTULA 50 0.0293
7 URINE LEUKOCYTE ESTERASE POSITIVE 20 0.0286
8 APPLICATION SITE PAPULES 30 0.0283
9 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 30 0.0282
10 APPLICATION SITE PRURITUS 619 0.0273
11 APPLICATION SITE RASH 351 0.0255
12 URINARY SEDIMENT PRESENT 16 0.0248
13 APPLICATION SITE WARMTH 31 0.0243
14 APPLICATION SITE DISCOMFORT 43 0.0239
15 PRODUCT ADHESION ISSUE 843 0.0236
16 RADICULOPATHY 60 0.0227
17 MONOCYTE PERCENTAGE INCREASED 15 0.0212
18 APPLICATION SITE BURN 99 0.0201
19 APPLICATION SITE DISCOLOURATION 81 0.0199
20 NEUROGENIC BLADDER 42 0.0199
21 APPLICATION SITE BRUISE 19 0.0195
22 APPLICATION SITE INFLAMMATION 27 0.0195
23 NEPHROGENIC ANAEMIA 88 0.0190
24 RED BLOOD CELLS URINE POSITIVE 18 0.0186
25 DRUG ADMINISTERED AT INAPPROPRIATE SITE 192 0.0182
26 PROCTITIS 51 0.0182
27 DRUG EFFECT DELAYED 76 0.0167
28 APPLICATION SITE IRRITATION 206 0.0165
29 HYPERPARATHYROIDISM SECONDARY 41 0.0163
30 DRUG EFFECT VARIABLE 18 0.0159
31 APPLICATION SITE EROSION 20 0.0155
32 BLADDER CATHETERISATION 15 0.0155
33 DRY AGE-RELATED MACULAR DEGENERATION 17 0.0153
34 CULTURE URINE POSITIVE 21 0.0149
35 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 27 0.0144
36 BLADDER PAIN 44 0.0138
37 CYSTITIS INTERSTITIAL 22 0.0137
38 BLADDER DYSFUNCTION 14 0.0136
39 LYMPHOCYTE PERCENTAGE DECREASED 18 0.0134
40 URINE ANALYSIS ABNORMAL 40 0.0134
41 WHITE BLOOD CELLS URINE POSITIVE 25 0.0133
42 REBOUND ACID HYPERSECRETION 40 0.0132
43 CHRONIC SINUSITIS 46 0.0122
44 APPLICATION SITE SCAR 15 0.0120
45 URINARY INCONTINENCE 351 0.0118
46 DRUG EFFECT DECREASED 635 0.0118
47 BLADDER DISORDER 116 0.0117
48 APPLICATION SITE PAIN 257 0.0117
49 MICTURITION URGENCY 133 0.0116
50 APPLICATION SITE URTICARIA 26 0.0116
51 ESSENTIAL HYPERTENSION 21 0.0115
52 PRODUCT PACKAGING ISSUE 106 0.0111
53 URINE ODOUR ABNORMAL 61 0.0104
54 URINARY TRACT INFECTION BACTERIAL 26 0.0103
55 MACULOPATHY 36 0.0101
56 INCONTINENCE 105 0.0099
57 NOCTURIA 117 0.0096
58 URINE ABNORMALITY 42 0.0092
59 DRY MOUTH 697 0.0086
60 POLLAKIURIA 354 0.0085
61 APPLICATION SITE SWELLING 41 0.0082
62 MUSCLE SPASTICITY 98 0.0080
63 APPLICATION SITE VESICLES 50 0.0077
64 URINARY RETENTION 244 0.0073
65 APPLICATION SITE EXFOLIATION 30 0.0073
66 BLOOD PRESSURE SYSTOLIC ABNORMAL 18 0.0073
67 WHEELCHAIR USER 32 0.0072
68 CHRONIC KIDNEY DISEASE 540 0.0071
69 WALKING AID USER 46 0.0070
70 END STAGE RENAL DISEASE 127 0.0070
71 MACULAR DEGENERATION 82 0.0069
72 PERONEAL NERVE PALSY 39 0.0069
73 EOSINOPHIL COUNT DECREASED 16 0.0067
74 ESCHERICHIA URINARY TRACT INFECTION 27 0.0063
75 URINARY TRACT INFECTION 1077 0.0063
76 CYSTITIS 201 0.0063
77 PRE-EXISTING CONDITION IMPROVED 39 0.0062
78 URINARY TRACT DISORDER 28 0.0062
79 ENURESIS 25 0.0062
80 DERMATITIS CONTACT 70 0.0061
81 MEDICATION RESIDUE PRESENT 29 0.0061
82 MICTURITION DISORDER 21 0.0061
83 DECUBITUS ULCER 49 0.0060
84 ORAL CANDIDIASIS 78 0.0059
85 MULTIPLE SCLEROSIS RELAPSE 405 0.0059
86 HAEMORRHAGE URINARY TRACT 15 0.0059
87 MULTIPLE SCLEROSIS 274 0.0057
88 SKIN ABRASION 27 0.0057
89 FREEZING PHENOMENON 21 0.0057
90 UROSEPSIS 52 0.0056
91 FAECAL INCONTINENCE 27 0.0056
92 RENAL TUBULAR NECROSIS 55 0.0056
93 DYSURIA 205 0.0056
94 BLOOD PRESSURE DIASTOLIC ABNORMAL 14 0.0055
95 TRIGEMINAL NEURALGIA 22 0.0055
96 TONGUE ULCERATION 18 0.0053
97 BALANCE DISORDER 458 0.0053
98 CEREBRAL ATROPHY 21 0.0053
99 VAGINAL DISCHARGE 53 0.0052
100 FIBULA FRACTURE 15 0.0052
101 APPLICATION SITE HAEMORRHAGE 14 0.0051
102 INCORRECT DRUG ADMINISTRATION DURATION 143 0.0051
103 APPLICATION SITE DRYNESS 17 0.0050
104 LACERATION 47 0.0050
105 BODY HEIGHT DECREASED 53 0.0050
106 FAECALOMA 27 0.0049
107 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
108 SUSPECTED SUICIDE 23 0.0049
109 SPINAL OSTEOARTHRITIS 43 0.0049
110 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 347 0.0049
111 PARAESTHESIA ORAL 70 0.0048
112 BENIGN PROSTATIC HYPERPLASIA 25 0.0048
113 APPLICATION SITE REACTION 34 0.0048
114 VULVOVAGINAL MYCOTIC INFECTION 19 0.0048
115 SKIN IRRITATION 221 0.0048
116 VAGINAL INFECTION 22 0.0047
117 ANAL INCONTINENCE 42 0.0047
118 HALLUCINATION, VISUAL 98 0.0046
119 KIDNEY INFECTION 91 0.0046
120 ATRIOVENTRICULAR BLOCK FIRST DEGREE 20 0.0046
121 SPINAL STENOSIS 19 0.0046
122 TONGUE DISCOLOURATION 20 0.0046
123 FALL 1506 0.0045
124 BONE EROSION 16 0.0045
125 SKIN INJURY 15 0.0045
126 IMPAIRED GASTRIC EMPTYING 61 0.0045
127 HEPATIC ENZYME ABNORMAL 22 0.0044
128 MONOCYTE COUNT INCREASED 16 0.0044
129 APLASTIC ANAEMIA 23 0.0044
130 SLEEP APNOEA SYNDROME 84 0.0044
131 GOITRE 18 0.0044
132 ATAXIA 52 0.0044
133 BLOOD URINE PRESENT 83 0.0044
134 DELIRIUM 150 0.0043
135 HALLUCINATIONS, MIXED 18 0.0043
136 HYDRONEPHROSIS 32 0.0043
137 PRODUCT RESIDUE PRESENT 23 0.0043
138 ILEUS PARALYTIC 19 0.0043
139 THERAPY CESSATION 217 0.0042
140 RENAL INJURY 125 0.0042
141 CATATONIA 22 0.0042
142 INCOHERENT 27 0.0042
143 NASAL DRYNESS 26 0.0041
144 LIGAMENT SPRAIN 41 0.0041
145 NYSTAGMUS 22 0.0041
146 BIPOLAR DISORDER 45 0.0041
147 VITAMIN D DEFICIENCY 40 0.0041
148 RED CELL DISTRIBUTION WIDTH INCREASED 17 0.0041
149 DIVERTICULUM 29 0.0041
150 VULVOVAGINAL DISCOMFORT 18 0.0041
151 PROSTATOMEGALY 16 0.0041
152 TEMPERATURE INTOLERANCE 42 0.0041
153 ANKLE FRACTURE 63 0.0041
154 TENDON DISORDER 26 0.0040
155 BLOOD PRESSURE SYSTOLIC DECREASED 18 0.0040
156 NEPHROLITHIASIS 181 0.0039
157 VULVOVAGINAL PAIN 19 0.0039
158 CENTRAL NERVOUS SYSTEM LESION 54 0.0039
159 LOWER GASTROINTESTINAL HAEMORRHAGE 29 0.0039
160 ROTATOR CUFF SYNDROME 50 0.0039
161 MENTAL STATUS CHANGES 108 0.0039
162 TRISMUS 20 0.0039
163 POOR VENOUS ACCESS 40 0.0039
164 PRODUCT QUALITY ISSUE 522 0.0038
165 BLOOD CREATINE INCREASED 17 0.0038
166 TIBIA FRACTURE 18 0.0038
167 WRIST FRACTURE 46 0.0038
168 DRY THROAT 39 0.0038
169 DYSSTASIA 112 0.0038
170 RASH ERYTHEMATOUS 183 0.0038
171 GAIT DISTURBANCE 732 0.0038
172 HAND FRACTURE 27 0.0038
173 DRUG EFFECT INCOMPLETE 138 0.0038
174 SALIVARY HYPERSECRETION 38 0.0038
175 MOBILITY DECREASED 272 0.0038
176 HYPOVOLAEMIA 22 0.0038
177 INTERVERTEBRAL DISC PROTRUSION 81 0.0037
178 BLOOD PRESSURE DIASTOLIC INCREASED 17 0.0037
179 INTERVERTEBRAL DISC DEGENERATION 34 0.0037
180 TRIGGER FINGER 15 0.0037
181 DIVERTICULUM INTESTINAL 16 0.0037
182 CONCUSSION 28 0.0036
183 PARKINSONISM 35 0.0036
184 OSTEOARTHRITIS 152 0.0036
185 EXPIRED PRODUCT ADMINISTERED 119 0.0036
186 DECREASED INTEREST 21 0.0036
187 MUSCULAR WEAKNESS 404 0.0036
188 RENAL CYST 28 0.0035
189 INTERVERTEBRAL DISC DISORDER 15 0.0035
190 EXOSTOSIS 32 0.0035
191 CHROMATURIA 79 0.0035
192 ECONOMIC PROBLEM 53 0.0035
193 CONSTIPATION 762 0.0035
194 PERIPHERAL VASCULAR DISORDER 18 0.0035
195 LYMPHOCYTE COUNT DECREASED 61 0.0034
196 HOSPICE CARE 34 0.0034
197 PRODUCT ADMINISTRATION INTERRUPTED 27 0.0034
198 MOTOR DYSFUNCTION 35 0.0034
199 FLANK PAIN 32 0.0034
200 HAEMORRHAGIC ANAEMIA 15 0.0034
201 SCOLIOSIS 21 0.0034
202 BRADYKINESIA 20 0.0034
203 VULVOVAGINAL PRURITUS 17 0.0034
204 SOMNAMBULISM 22 0.0033
205 ODYNOPHAGIA 20 0.0033
206 DYSGRAPHIA 22 0.0033
207 BURNING SENSATION 234 0.0033
208 WRONG TECHNIQUE IN DRUG USAGE PROCESS 121 0.0033
209 DEMENTIA 93 0.0033
210 DYSARTHRIA 125 0.0033
211 HIP FRACTURE 106 0.0033
212 BLOOD PRESSURE FLUCTUATION 79 0.0033
213 HALLUCINATION 248 0.0033
214 SKIN WARM 19 0.0033
215 RENAL FAILURE 433 0.0033
216 GLOMERULAR FILTRATION RATE DECREASED 40 0.0033
217 BLOOD MAGNESIUM DECREASED 28 0.0032
218 ERYTHEMA 664 0.0032
219 HAEMATOCRIT DECREASED 64 0.0032
220 CHAPPED LIPS 14 0.0032
221 INITIAL INSOMNIA 33 0.0032
222 UPPER LIMB FRACTURE 64 0.0032
223 ONYCHOCLASIS 22 0.0032
224 SPINAL COLUMN STENOSIS 15 0.0032
225 KLEBSIELLA INFECTION 16 0.0032
226 APHONIA 44 0.0031
227 MEMORY IMPAIRMENT 432 0.0031
228 UNRESPONSIVE TO STIMULI 81 0.0031
229 LIMB DISCOMFORT 97 0.0031
230 RESTLESS LEGS SYNDROME 57 0.0031
231 HEAD INJURY 99 0.0031
232 PSYCHOLOGICAL TRAUMA 27 0.0031
233 NEURALGIA 76 0.0031
234 MOUTH SWELLING 18 0.0031
235 ACUTE KIDNEY INJURY 476 0.0031
236 CONFUSIONAL STATE 502 0.0031
237 HIATUS HERNIA 40 0.0031
238 TOOTH FRACTURE 34 0.0031
239 DENTAL CARIES 34 0.0031
240 DRUG INEFFECTIVE 4005 0.0030
241 SPINAL COMPRESSION FRACTURE 25 0.0030
242 ARTHRITIS INFECTIVE 14 0.0030
243 ENCEPHALOPATHY 74 0.0030
244 COORDINATION ABNORMAL 42 0.0030
245 HYSTERECTOMY 26 0.0030
246 COGNITIVE DISORDER 140 0.0030
247 GAIT INABILITY 100 0.0030
248 DIZZINESS POSTURAL 29 0.0030
249 TUBULOINTERSTITIAL NEPHRITIS 56 0.0030
250 GRANULOCYTOPENIA 17 0.0030
251 THERMAL BURN 21 0.0030
252 ABNORMAL LOSS OF WEIGHT 20 0.0029
253 RASH PRURITIC 159 0.0029
254 EAR PAIN 57 0.0029
255 SKIN REACTION 41 0.0029
256 INTESTINAL ISCHAEMIA 16 0.0029
257 POLYP 19 0.0029
258 OSTEOPENIA 44 0.0029
259 HYPOKINESIA 42 0.0029
260 SINUS DISORDER 57 0.0029
261 ABASIA 71 0.0029
262 BLOOD IRON DECREASED 34 0.0029
263 FOOT FRACTURE 54 0.0028
264 TOOTH ABSCESS 29 0.0028
265 MUSCLE TIGHTNESS 46 0.0028
266 MUSCULOSKELETAL DISORDER 54 0.0028
267 HEMIPARESIS 48 0.0028
268 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
269 CONTUSION 272 0.0028
270 FACIAL PARALYSIS 24 0.0028
271 FREQUENT BOWEL MOVEMENTS 76 0.0028
272 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 23 0.0028
273 PARANOIA 48 0.0028
274 GASTROOESOPHAGEAL REFLUX DISEASE 224 0.0028
275 SCIATICA 44 0.0028
276 ATRIAL FLUTTER 22 0.0028
277 ANHEDONIA 72 0.0027
278 AMNESIA 178 0.0027
279 THERAPEUTIC RESPONSE UNEXPECTED 122 0.0027
280 ARTERIOSCLEROSIS CORONARY ARTERY 18 0.0027
281 RECTAL HAEMORRHAGE 116 0.0027
282 ORTHOSTATIC HYPOTENSION 47 0.0027
283 HOT FLUSH 203 0.0027
284 THERAPEUTIC RESPONSE CHANGED 17 0.0027
285 HEART RATE DECREASED 94 0.0027
286 LABORATORY TEST ABNORMAL 79 0.0027
287 COLITIS ISCHAEMIC 18 0.0027
288 BLOOD POTASSIUM DECREASED 80 0.0027
289 HAEMATURIA 91 0.0027
290 PHARYNGEAL SWELLING 26 0.0027
291 PYELONEPHRITIS 23 0.0027
292 TOOTH DISORDER 59 0.0027
293 BLOOD SODIUM DECREASED 50 0.0026
294 PRURITUS 1018 0.0026
295 CARPAL TUNNEL SYNDROME 37 0.0026
296 DELUSION 41 0.0026
297 NEUTROPHIL COUNT INCREASED 27 0.0026
298 DYSPHAGIA 250 0.0026
299 RED BLOOD CELL COUNT DECREASED 75 0.0026
300 PERIPHERAL COLDNESS 36 0.0026
301 HAIR TEXTURE ABNORMAL 35 0.0026
302 HYPERSOMNIA 75 0.0026
303 UPPER GASTROINTESTINAL HAEMORRHAGE 44 0.0026
304 GASTROENTERITIS 38 0.0026
305 MYASTHENIA GRAVIS 21 0.0026
306 SPINAL OPERATION 32 0.0026
307 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 16 0.0026
308 POST PROCEDURAL INFECTION 21 0.0026
309 ARTHRITIS 203 0.0026
310 RIB FRACTURE 53 0.0026
311 RESPIRATORY ARREST 71 0.0026
312 SKIN LACERATION 28 0.0026
313 JOINT INJURY 55 0.0026
314 BLOOD PRESSURE SYSTOLIC INCREASED 50 0.0026
315 PNEUMONIA ASPIRATION 64 0.0026
316 SPEECH DISORDER 134 0.0026
317 JOINT DISLOCATION 27 0.0026
318 MOVEMENT DISORDER 82 0.0026
319 ESCHERICHIA INFECTION 21 0.0026
320 IMPAIRED DRIVING ABILITY 29 0.0025
321 DISORIENTATION 101 0.0025
322 OSTEOMYELITIS 46 0.0025
323 GLUCOSE TOLERANCE IMPAIRED 15 0.0025
324 LIP DRY 23 0.0025
325 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 26 0.0025
326 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 132 0.0025
327 THIRST 45 0.0025
328 TRICUSPID VALVE INCOMPETENCE 20 0.0025
329 ACCIDENT 30 0.0025
330 SCAR 43 0.0025
331 PRODUCT LABEL ISSUE 17 0.0025
332 DRY EYE 125 0.0025
333 CELLULITIS 126 0.0025
334 HYPOAESTHESIA 374 0.0025
335 MUSCULOSKELETAL DISCOMFORT 43 0.0025
336 ACUTE RESPIRATORY FAILURE 48 0.0025
337 PULMONARY MASS 37 0.0025
338 SKIN DISCOLOURATION 114 0.0025
339 LYMPHOPENIA 35 0.0025
340 COMPLETED SUICIDE 206 0.0025
341 BACK DISORDER 40 0.0025
342 ORAL PAIN 55 0.0025
343 OSTEOPOROSIS 101 0.0025
344 PRODUCT DOSE OMISSION 160 0.0024
345 LOWER LIMB FRACTURE 47 0.0024
346 EATING DISORDER 52 0.0024
347 ASTHENIA 918 0.0024
348 PELVIC FRACTURE 19 0.0024
349 DYSPEPSIA 240 0.0024
350 SMALL INTESTINAL OBSTRUCTION 30 0.0024
351 CLOSTRIDIUM DIFFICILE INFECTION 53 0.0024
352 IRRITABLE BOWEL SYNDROME 52 0.0024
353 OLIGURIA 15 0.0024
354 DYSKINESIA 98 0.0024
355 HAEMATOCHEZIA 133 0.0024
356 SOMNOLENCE 485 0.0024
357 HEMIPLEGIA 20 0.0024
358 URINE OUTPUT DECREASED 21 0.0024
359 VISION BLURRED 329 0.0024
360 MENINGITIS 16 0.0024
361 LIMB INJURY 65 0.0024
362 BRONCHITIS 177 0.0024
363 BACK INJURY 26 0.0024
364 DEPRESSION 543 0.0024
365 GRAND MAL CONVULSION 22 0.0024
366 PERIPHERAL SWELLING 367 0.0024
367 ASPIRATION 26 0.0024
368 BACK PAIN 551 0.0024
369 DIZZINESS 1177 0.0024
370 BONE DISORDER 43 0.0024
371 CATARACT OPERATION 14 0.0024
372 NEPHROPATHY 22 0.0024
373 BOWEL MOVEMENT IRREGULARITY 18 0.0023
374 COLITIS 89 0.0023
375 EYE MOVEMENT DISORDER 16 0.0023
376 PSYCHOTIC DISORDER 69 0.0023
377 THYROID DISORDER 36 0.0023
378 OXYGEN SATURATION DECREASED 131 0.0023
379 MUSCULOSKELETAL CHEST PAIN 36 0.0023
380 PROSTATIC SPECIFIC ANTIGEN INCREASED 32 0.0023
381 ROAD TRAFFIC ACCIDENT 97 0.0023
382 LYMPHOEDEMA 16 0.0023
383 BURSITIS 28 0.0023
384 SENSORY DISTURBANCE 37 0.0023
385 MITRAL VALVE INCOMPETENCE 26 0.0023
386 MUSCULOSKELETAL STIFFNESS 201 0.0023
387 HIP ARTHROPLASTY 35 0.0023
388 MUSCLE SPASMS 419 0.0023
389 PRODUCT PHYSICAL ISSUE 46 0.0023
390 DISCOMFORT 139 0.0023
391 SINUS BRADYCARDIA 22 0.0023
392 IRON DEFICIENCY ANAEMIA 21 0.0023
393 DIPLOPIA 59 0.0023
394 PROCEDURAL PAIN 63 0.0023
395 HALLUCINATION, AUDITORY 36 0.0023
396 RENAL PAIN 24 0.0023
397 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 20 0.0023
398 MUSCLE RIGIDITY 27 0.0023
399 DEHYDRATION 301 0.0023
400 SYNCOPE 225 0.0022
401 SENSORY LOSS 18 0.0022
402 PARALYSIS 32 0.0022
403 BODY TEMPERATURE DECREASED 22 0.0022
404 SEPSIS 249 0.0022
405 KNEE ARTHROPLASTY 47 0.0022
406 POOR QUALITY SLEEP 48 0.0022
407 FRUSTRATION TOLERANCE DECREASED 18 0.0022
408 IMPAIRED QUALITY OF LIFE 32 0.0022
409 PRURITUS GENERALISED 48 0.0022
410 LIPASE INCREASED 17 0.0022
411 SPINAL DISORDER 21 0.0022
412 HERPES ZOSTER 127 0.0022
413 BLOOD UREA INCREASED 37 0.0022
414 LETHARGY 127 0.0022
415 PRESCRIBED UNDERDOSE 44 0.0022
416 HAEMORRHOIDS 43 0.0022
417 CHOKING 43 0.0022
418 FAECES SOFT 16 0.0022
419 CATARACT 131 0.0022
420 OESOPHAGITIS 24 0.0022
421 MUSCLE STRAIN 19 0.0022
422 HYPERAESTHESIA 18 0.0022
423 BLISTER 123 0.0022
424 CORONARY ARTERY OCCLUSION 30 0.0022
425 VERTIGO 133 0.0022
426 DYSPNOEA EXERTIONAL 82 0.0022
427 PRODUCT USE ISSUE 409 0.0022
428 CYST 27 0.0022
429 DROOLING 15 0.0022
430 BLOOD PRESSURE DIASTOLIC DECREASED 16 0.0022
431 NERVE COMPRESSION 20 0.0022
432 ATRIAL FIBRILLATION 211 0.0022
433 FOOT DEFORMITY 24 0.0022
434 WEIGHT DECREASED 604 0.0022
435 LIP SWELLING 72 0.0022
436 PRODUCT USE COMPLAINT 34 0.0022
437 EXTRASYSTOLES 15 0.0021
438 SINUS CONGESTION 29 0.0021
439 FURUNCLE 17 0.0021
440 MIDDLE INSOMNIA 40 0.0021
441 DEFAECATION URGENCY 15 0.0021
442 HYPERKALAEMIA 75 0.0021
443 POST PROCEDURAL COMPLICATION 41 0.0021
444 INFUSION SITE ERYTHEMA 18 0.0021
445 SPINAL PAIN 25 0.0021
446 SARS-COV-2 TEST POSITIVE 28 0.0021
447 GASTROINTESTINAL INFECTION 19 0.0021
448 COVID-19 PNEUMONIA 25 0.0021
449 PSYCHOMOTOR HYPERACTIVITY 35 0.0021
450 SEDATION 55 0.0021
451 TOOTHACHE 38 0.0021
452 HYPERTHERMIA 16 0.0021
453 MYOCARDITIS 24 0.0021
454 DRUG INTERACTION 332 0.0021
455 HYPERLIPIDAEMIA 25 0.0021
456 RASH MACULAR 73 0.0021
457 PRODUCT DOSE OMISSION IN ERROR 59 0.0021
458 DRUG PRESCRIBING ERROR 40 0.0021
459 EMPHYSEMA 21 0.0021
460 SWOLLEN TONGUE 65 0.0021
461 FLUSHING 211 0.0021
462 HYPOPHAGIA 53 0.0021
463 TONGUE DISORDER 15 0.0021
464 INTESTINAL OBSTRUCTION 78 0.0021
465 INSOMNIA 550 0.0021
466 HAIR DISORDER 17 0.0021
467 FIBROMYALGIA 50 0.0021
468 HYPOAESTHESIA ORAL 31 0.0021
469 BEDRIDDEN 27 0.0021
470 MUSCLE ATROPHY 26 0.0021
471 GROIN PAIN 18 0.0020
472 TREMOR 339 0.0020
473 MULTIPLE ALLERGIES 16 0.0020
474 FUNGAL INFECTION 68 0.0020
475 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
476 FATIGUE 1585 0.0020
477 VITREOUS FLOATERS 20 0.0020
478 PARAESTHESIA 320 0.0020
479 SUBDURAL HAEMATOMA 29 0.0020
480 VISUAL IMPAIRMENT 251 0.0020
481 MENTAL IMPAIRMENT 49 0.0020
482 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 97 0.0020
483 ARTERIOSCLEROSIS 19 0.0020
484 INABILITY TO AFFORD MEDICATION 20 0.0020
485 HAIR COLOUR CHANGES 25 0.0020
486 LOCAL SWELLING 35 0.0020
487 PAIN IN EXTREMITY 588 0.0020
488 SCRATCH 21 0.0020
489 BASAL CELL CARCINOMA 31 0.0020
490 DYSPHONIA 116 0.0020
491 GASTRITIS 52 0.0020
492 SCHIZOPHRENIA 24 0.0020
493 FEEDING DISORDER 40 0.0020
494 BLOOD PRESSURE ABNORMAL 39 0.0020
495 OEDEMA PERIPHERAL 239 0.0020
496 BLOOD CALCIUM DECREASED 22 0.0020
497 TRANSIENT ISCHAEMIC ATTACK 66 0.0020
498 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 14 0.0020
499 SPINAL FRACTURE 39 0.0019
500 FEELING JITTERY 37 0.0019
501 FLATULENCE 110 0.0019
502 TENDONITIS 30 0.0019
503 WHITE BLOOD CELL COUNT DECREASED 210 0.0019
504 PNEUMONIA 627 0.0019
505 CONDITION AGGRAVATED 587 0.0019
506 RASH 841 0.0019
507 SCAB 22 0.0019
508 CHOLECYSTECTOMY 22 0.0019
509 HAEMORRHAGIC STROKE 15 0.0019
510 TENDERNESS 20 0.0019
511 UNEVALUABLE EVENT 145 0.0019
512 INFUSION RELATED REACTION 127 0.0019
513 DIVERTICULITIS 53 0.0019
514 ERUCTATION 37 0.0019
515 DISTURBANCE IN ATTENTION 103 0.0019
516 GASTROINTESTINAL HAEMORRHAGE 159 0.0019
517 LOCALISED INFECTION 46 0.0019
518 FRACTURE 36 0.0019
519 WOUND 53 0.0019
520 MYOSITIS 17 0.0019
521 NEUROPATHY PERIPHERAL 180 0.0019
522 NERVE INJURY 21 0.0019
523 RESPIRATORY TRACT CONGESTION 30 0.0019
524 EYE DISORDER 62 0.0019
525 HYPOKALAEMIA 87 0.0019
526 GINGIVAL PAIN 15 0.0019
527 BLOOD PRESSURE INCREASED 287 0.0019
528 OPTIC NEURITIS 17 0.0019
529 HYPOMAGNESAEMIA 26 0.0019
530 HEAD DISCOMFORT 33 0.0019
531 ATELECTASIS 18 0.0019
532 THERAPY INTERRUPTED 133 0.0019
533 NECK PAIN 104 0.0019
534 MASS 26 0.0019
535 STATUS EPILEPTICUS 21 0.0019
536 DRUG ADMINISTRATION ERROR 57 0.0019
537 NERVOUSNESS 97 0.0019
538 ILEUS 23 0.0018
539 ANGINA PECTORIS 53 0.0018
540 CARDIAC MURMUR 16 0.0018
541 BLOOD POTASSIUM INCREASED 30 0.0018
542 BLOOD GLUCOSE ABNORMAL 34 0.0018
543 INTERNAL HAEMORRHAGE 21 0.0018
544 INFECTION 266 0.0018
545 CANDIDA INFECTION 31 0.0018
546 ACIDOSIS 14 0.0018
547 POLYURIA 15 0.0018
548 ABNORMAL FAECES 15 0.0018
549 CHOLELITHIASIS 60 0.0018
550 FEELING ABNORMAL 438 0.0018
551 SLEEP DISORDER 129 0.0018
552 OROPHARYNGEAL PAIN 169 0.0018
553 BACTERIAL INFECTION 34 0.0018
554 ABDOMINAL PAIN 423 0.0018
555 ACTIVITIES OF DAILY LIVING IMPAIRED 36 0.0018
556 HYPOTHYROIDISM 58 0.0018
557 WEIGHT FLUCTUATION 19 0.0018
558 ANXIETY 516 0.0018
559 INFLUENZA 202 0.0018
560 BRADYCARDIA 96 0.0018
561 PAIN 1109 0.0018
562 THROAT IRRITATION 81 0.0018
563 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 128 0.0018
564 UPPER RESPIRATORY TRACT INFECTION 83 0.0018
565 FEELING COLD 50 0.0018
566 COVID-19 315 0.0018
567 FEELING HOT 110 0.0018
568 CHEST PAIN 332 0.0018
569 FLUID RETENTION 91 0.0018
570 STAPHYLOCOCCAL INFECTION 59 0.0018
571 APHASIA 54 0.0018
572 LIVER FUNCTION TEST ABNORMAL 52 0.0018
573 LOSS OF CONSCIOUSNESS 229 0.0018
574 GLOSSODYNIA 40 0.0018
575 HYPERTENSION 378 0.0018
576 ABNORMAL DREAMS 49 0.0018
577 LEUKOCYTOSIS 32 0.0018
578 SEASONAL ALLERGY 25 0.0018
579 INSURANCE ISSUE 27 0.0018
580 PAIN IN JAW 50 0.0018
581 SLUGGISHNESS 18 0.0018
582 ALOPECIA 346 0.0018
583 DECREASED ACTIVITY 19 0.0018
584 ANAEMIA 335 0.0018
585 VITAMIN D DECREASED 15 0.0018
586 INTERNATIONAL NORMALISED RATIO INCREASED 50 0.0018
587 HAEMOGLOBIN DECREASED 180 0.0018
588 GENERALISED TONIC-CLONIC SEIZURE 29 0.0018
589 DIARRHOEA 1130 0.0017
590 DRUG DOSE OMISSION 289 0.0017
591 INTENTIONAL PRODUCT MISUSE 153 0.0017
592 ARTHROPATHY 97 0.0017
593 TOOTH INFECTION 23 0.0017
594 CARDIAC FAILURE CONGESTIVE 140 0.0017
595 HYPONATRAEMIA 98 0.0017
596 INCREASED TENDENCY TO BRUISE 16 0.0017
597 BLOOD THYROID STIMULATING HORMONE INCREASED 16 0.0017
598 VENTRICULAR EXTRASYSTOLES 18 0.0017
599 CHILLS 203 0.0017
600 THERAPY CHANGE 17 0.0017
601 HEART RATE IRREGULAR 39 0.0017
602 HYPOTENSION 346 0.0017
603 MENTAL DISORDER 75 0.0017
604 ELECTROLYTE IMBALANCE 20 0.0017
605 DEPRESSED MOOD 91 0.0017
606 ABNORMAL BEHAVIOUR 68 0.0017
607 BLOOD PRESSURE DECREASED 114 0.0017
608 BODY TEMPERATURE INCREASED 35 0.0017
609 HYPOGLYCAEMIA 83 0.0017
610 BLOOD CALCIUM INCREASED 15 0.0017
611 HERNIA 33 0.0017
612 INJECTION SITE EXTRAVASATION 21 0.0017
613 HAEMATEMESIS 43 0.0017
614 RASH PAPULAR 38 0.0017
615 WHITE BLOOD CELL COUNT INCREASED 65 0.0017
616 THROMBOSIS 136 0.0017
617 SINUS TACHYCARDIA 24 0.0017
618 GASTRIC DISORDER 58 0.0017
619 PLATELET COUNT INCREASED 22 0.0017
620 FULL BLOOD COUNT DECREASED 34 0.0017
621 PRESYNCOPE 41 0.0017
622 CORONARY ARTERY DISEASE 51 0.0017
623 TASTE DISORDER 34 0.0017
624 AGITATION 123 0.0017
625 GOUT 30 0.0017
626 DISABILITY 33 0.0017
627 MALAISE 730 0.0017
628 SINUSITIS 170 0.0017
629 BLOOD CHOLESTEROL INCREASED 77 0.0017
630 ABDOMINAL DISCOMFORT 277 0.0016
631 MUSCLE TWITCHING 38 0.0016
632 NIGHTMARE 57 0.0016
633 DECREASED APPETITE 382 0.0016
634 MIGRAINE 157 0.0016
635 EPISTAXIS 123 0.0016
636 CONVULSION 94 0.0016
637 RETCHING 35 0.0016
638 MADAROSIS 19 0.0016
639 COLITIS ULCERATIVE 73 0.0016
640 ABDOMINAL PAIN UPPER 336 0.0016
641 HYPOACUSIS 70 0.0016
642 RENAL FAILURE ACUTE 69 0.0016
643 CARDIOMEGALY 20 0.0016
644 HEADACHE 1019 0.0016
645 CARDIOMYOPATHY 24 0.0016
646 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 89 0.0016
647 FEMUR FRACTURE 50 0.0016
648 GINGIVAL BLEEDING 22 0.0016
649 HEPATIC STEATOSIS 30 0.0016
650 RENAL DISORDER 75 0.0016
651 MALNUTRITION 18 0.0016
652 INFLAMMATION 83 0.0016
653 APPENDICITIS 15 0.0016
654 MUCOSAL INFLAMMATION 42 0.0016
655 ABDOMINAL DISTENSION 167 0.0016
656 BRAIN INJURY 16 0.0016
657 DEPRESSED LEVEL OF CONSCIOUSNESS 63 0.0016
658 PRODUCTIVE COUGH 76 0.0016
659 SKIN ULCER 41 0.0016
660 NAUSEA 1255 0.0016
661 CHEST DISCOMFORT 162 0.0016
662 SPUTUM DISCOLOURED 15 0.0016
663 SWELLING 148 0.0016
664 INFLUENZA LIKE ILLNESS 130 0.0016
665 ULCER 25 0.0016
666 BLOOD TEST ABNORMAL 22 0.0016
667 RESTLESSNESS 57 0.0016
668 SKIN HAEMORRHAGE 23 0.0016
669 GASTROENTERITIS VIRAL 28 0.0015
670 PRESCRIBED OVERDOSE 30 0.0015
671 IMMUNODEFICIENCY 23 0.0015
672 HYPOXIA 54 0.0015
673 SKIN CANCER 33 0.0015
674 JOINT SWELLING 185 0.0015
675 PHARYNGITIS 19 0.0015
676 ELECTROCARDIOGRAM QT PROLONGED 55 0.0015
677 BLOOD TRIGLYCERIDES INCREASED 27 0.0015
678 TOOTH EXTRACTION 19 0.0015
679 GASTRIC ULCER 29 0.0015
680 FEAR 41 0.0015
681 CEREBROVASCULAR ACCIDENT 258 0.0015
682 FAECES DISCOLOURED 33 0.0015
683 MOUTH ULCERATION 32 0.0015
684 INCREASED APPETITE 29 0.0015
685 PULMONARY CONGESTION 20 0.0015
686 VOMITING 713 0.0015
687 COUGH 424 0.0015
688 PULMONARY FIBROSIS 29 0.0015
689 DERMATITIS ALLERGIC 19 0.0015
690 MYOCLONUS 18 0.0015
691 HYPERSENSITIVITY 280 0.0015
692 MUSCULOSKELETAL PAIN 79 0.0015
693 SEIZURE 174 0.0015
694 HAEMOPTYSIS 42 0.0015
695 LOWER RESPIRATORY TRACT INFECTION 68 0.0015
696 OFF LABEL USE 1309 0.0015
697 SKIN LESION 41 0.0015
698 MYOCARDIAL ISCHAEMIA 17 0.0015
699 IMPAIRED HEALING 49 0.0015
700 EXTRAPYRAMIDAL DISORDER 37 0.0015
701 PULMONARY HYPERTENSION 31 0.0015
702 WEIGHT INCREASED 333 0.0015
703 JOINT STIFFNESS 39 0.0015
704 DRUG WITHDRAWAL SYNDROME NEONATAL 22 0.0015
705 PANIC ATTACK 54 0.0015
706 TINNITUS 68 0.0015
707 THROAT TIGHTNESS 40 0.0015
708 DEEP VEIN THROMBOSIS 96 0.0015
709 INTENTIONAL DOSE OMISSION 42 0.0015
710 BONE PAIN 86 0.0015
711 HAEMATOMA 38 0.0015
712 GLYCOSYLATED HAEMOGLOBIN INCREASED 37 0.0015
713 EAR INFECTION 39 0.0015
714 ARTHRALGIA 609 0.0015
715 ABDOMINAL PAIN LOWER 37 0.0015
716 RESPIRATORY TRACT INFECTION 38 0.0015
717 GASTROINTESTINAL PAIN 16 0.0015
718 GLAUCOMA 28 0.0015
719 TOOTH LOSS 30 0.0014
720 NASAL CONGESTION 85 0.0014
721 NERVOUS SYSTEM DISORDER 45 0.0014
722 ABSCESS 23 0.0014
723 PYREXIA 497 0.0014
724 HUNGER 20 0.0014
725 BACTERAEMIA 17 0.0014
726 PRODUCT ODOUR ABNORMAL 15 0.0014
727 PHARYNGEAL OEDEMA 22 0.0014
728 CHOLECYSTITIS 17 0.0014
729 SKIN INFECTION 16 0.0014
730 ASTHMA 161 0.0014
731 TREATMENT FAILURE 118 0.0014
732 BLOOD CREATINE PHOSPHOKINASE INCREASED 41 0.0014
733 EYE HAEMORRHAGE 19 0.0014
734 FULL BLOOD COUNT ABNORMAL 15 0.0014
735 MALIGNANT MELANOMA 19 0.0014
736 STOMATITIS 86 0.0014
737 BLINDNESS UNILATERAL 20 0.0014
738 TARDIVE DYSKINESIA 40 0.0014
739 QUALITY OF LIFE DECREASED 19 0.0014
740 DIABETES MELLITUS INADEQUATE CONTROL 25 0.0014
741 NASOPHARYNGITIS 259 0.0014
742 WITHDRAWAL SYNDROME 59 0.0014
743 LIVER FUNCTION TEST INCREASED 30 0.0014
744 TACHYCARDIA 124 0.0014
745 PULMONARY EMBOLISM 132 0.0014
746 PHARYNGITIS STREPTOCOCCAL 15 0.0014
747 VIRAL INFECTION 46 0.0014
748 SURGERY 81 0.0014
749 HYPERTHYROIDISM 20 0.0014
750 OBESITY 22 0.0014
751 PLEURAL EFFUSION 84 0.0014
752 PULMONARY THROMBOSIS 15 0.0014
753 BLOOD ALKALINE PHOSPHATASE INCREASED 34 0.0014
754 ORAL DISCOMFORT 19 0.0014
755 LUNG DISORDER 67 0.0014
756 DYSPNOEA 773 0.0014
757 MYALGIA 232 0.0014
758 OEDEMA 74 0.0014
759 CARDIO-RESPIRATORY ARREST 57 0.0014
760 PULMONARY OEDEMA 61 0.0014
761 POISONING 17 0.0014
762 TOXICITY TO VARIOUS AGENTS 228 0.0014
763 RASH GENERALISED 35 0.0014
764 SWELLING FACE 88 0.0014
765 BLINDNESS 55 0.0013
766 BLOOD CREATININE INCREASED 88 0.0013
767 GALLBLADDER DISORDER 24 0.0013
768 RESPIRATORY FAILURE 98 0.0013
769 HOSPITALISATION 206 0.0013
770 RHEUMATOID ARTHRITIS 152 0.0013
771 DIABETES MELLITUS 102 0.0013
772 JAUNDICE 36 0.0013
773 PRODUCT DOSE OMISSION ISSUE 393 0.0013
774 DRUG LEVEL INCREASED 22 0.0013
775 ADVERSE DRUG REACTION 119 0.0013
776 DRUG TOXICITY 18 0.0013
777 MOOD ALTERED 36 0.0013
778 SKIN DISORDER 44 0.0013
779 DYSGEUSIA 98 0.0013
780 TREATMENT NONCOMPLIANCE 72 0.0013
781 NODULE 17 0.0013
782 HEART RATE INCREASED 129 0.0013
783 DEAFNESS 34 0.0013
784 DEVICE RELATED INFECTION 20 0.0013
785 HYPERHIDROSIS 167 0.0013
786 THERAPEUTIC PRODUCT EFFECT DECREASED 58 0.0013
787 CRYING 47 0.0013
788 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
789 PALPITATIONS 151 0.0013
790 DYSTONIA 25 0.0013
791 THINKING ABNORMAL 24 0.0013
792 DRUG INTOLERANCE 124 0.0013
793 AGEUSIA 32 0.0013
794 ADVERSE REACTION 17 0.0013
795 INTENTIONAL PRODUCT USE ISSUE 112 0.0013
796 BRAIN FOG 20 0.0013
797 NIGHT SWEATS 41 0.0013
798 PRODUCT SUBSTITUTION ISSUE 73 0.0013
799 ILL-DEFINED DISORDER 77 0.0013
800 PELVIC PAIN 23 0.0013
801 BRONCHOSPASM 18 0.0013
802 CARDIAC DISORDER 118 0.0013
803 PNEUMOTHORAX 20 0.0013
804 PSORIATIC ARTHROPATHY 51 0.0013
805 RHINORRHOEA 81 0.0013
806 RENAL IMPAIRMENT 105 0.0012
807 INFUSION SITE PAIN 16 0.0012
808 ADVERSE EVENT 114 0.0012
809 NO THERAPEUTIC RESPONSE 15 0.0012
810 PRODUCT AVAILABILITY ISSUE 28 0.0012
811 ORAL HERPES 24 0.0012
812 SKIN BURNING SENSATION 88 0.0012
813 SKIN FISSURES 24 0.0012
814 MELAENA 27 0.0012
815 LIVER INJURY 30 0.0012
816 URTICARIA 204 0.0012
817 MULTIPLE FRACTURES 20 0.0012
818 IMMUNE SYSTEM DISORDER 16 0.0012
819 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 246 0.0012
820 DEVICE OCCLUSION 17 0.0012
821 VISUAL ACUITY REDUCED 40 0.0012
822 EMOTIONAL DISORDER 37 0.0012
823 SECRETION DISCHARGE 15 0.0012
824 INJURY 84 0.0012
825 METASTASES TO LIVER 21 0.0012
826 INJECTION SITE MASS 44 0.0012
827 CARDIAC ARREST 98 0.0012
828 EPILEPSY 36 0.0012
829 ISCHAEMIC STROKE 21 0.0012
830 PRODUCT PRESCRIBING ERROR 28 0.0012
831 ACCIDENTAL OVERDOSE 43 0.0012
832 EYE PAIN 66 0.0012
833 PHOTOPHOBIA 22 0.0012
834 FLUID OVERLOAD 17 0.0012
835 PLATELET COUNT DECREASED 124 0.0012
836 HEPATIC ENZYME INCREASED 79 0.0012
837 DRY SKIN 154 0.0012
838 UNDERDOSE 84 0.0011
839 GASTROINTESTINAL DISORDER 103 0.0011
840 ILLNESS 118 0.0011
841 BLOOD GLUCOSE DECREASED 55 0.0011
842 COAGULOPATHY 19 0.0011
843 AGGRESSION 57 0.0011
844 THERAPY NON-RESPONDER 51 0.0011
845 THERAPEUTIC RESPONSE DECREASED 68 0.0011
846 ACUTE MYOCARDIAL INFARCTION 33 0.0011
847 CEREBRAL HAEMORRHAGE 40 0.0011
848 THERAPEUTIC RESPONSE SHORTENED 37 0.0011
849 SNEEZING 25 0.0011
850 PAIN OF SKIN 30 0.0011
851 HYPOCALCAEMIA 21 0.0011
852 CEREBRAL INFARCTION 27 0.0011
853 GENERAL PHYSICAL HEALTH DETERIORATION 127 0.0011
854 WHEEZING 65 0.0011
855 COLON CANCER 16 0.0011
856 PANCYTOPENIA 60 0.0011
857 ANGER 36 0.0011
858 INCORRECT PRODUCT ADMINISTRATION DURATION 23 0.0011
859 INJECTION SITE REACTION 73 0.0011
860 PRODUCT DISPENSING ERROR 23 0.0011
861 BLOOD COUNT ABNORMAL 16 0.0011
862 SKIN EXFOLIATION 89 0.0011
863 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 190 0.0011
864 ERECTILE DYSFUNCTION 27 0.0011
865 EYE SWELLING 39 0.0010
866 CARDIAC FAILURE 84 0.0010
867 LYMPHADENOPATHY 37 0.0010
868 PRODUCT ADMINISTRATION ERROR 21 0.0010
869 PERICARDIAL EFFUSION 24 0.0010
870 GAMMA-GLUTAMYLTRANSFERASE INCREASED 23 0.0010
871 RESPIRATORY DISORDER 31 0.0010
872 INJECTION SITE HAEMATOMA 15 0.0010
873 MANIA 17 0.0010
874 COMPLICATION ASSOCIATED WITH DEVICE 15 0.0010
875 LUNG INFECTION 16 0.0010
876 EJECTION FRACTION DECREASED 16 0.0010
877 PHOTOSENSITIVITY REACTION 17 0.0010
878 SUICIDAL IDEATION 94 0.0010
879 COLD SWEAT 18 0.0010
880 DERMATITIS 21 0.0010
881 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 17 0.0010
882 EMOTIONAL DISTRESS 121 0.0010
883 CIRCULATORY COLLAPSE 17 0.0010
884 ASPARTATE AMINOTRANSFERASE INCREASED 53 0.0010
885 FEBRILE NEUTROPENIA 66 0.0010
886 ANGIOEDEMA 44 0.0010
887 BLOOD GLUCOSE INCREASED 187 0.0010
888 EYE IRRITATION 57 0.0010
889 SEROTONIN SYNDROME 19 0.0010
890 IMPAIRED WORK ABILITY 21 0.0010
891 PANCREATITIS ACUTE 22 0.0010
892 INCORRECT DOSE ADMINISTERED 223 0.0010
893 PSORIASIS 127 0.0010
894 DISEASE PROGRESSION 115 0.0010
895 MEDICATION ERROR 54 0.0010
896 DISEASE RECURRENCE 46 0.0010
897 ALANINE AMINOTRANSFERASE INCREASED 59 0.0010
898 INTENTIONAL DRUG MISUSE 20 0.0010
899 EYE PRURITUS 32 0.0010
900 MYOCARDIAL INFARCTION 166 0.0010
901 DEVICE ISSUE 85 0.0009
902 COMA 45 0.0009
903 MOOD SWINGS 30 0.0009
904 NEEDLE ISSUE 27 0.0009
905 OCULAR HYPERAEMIA 44 0.0009
906 LUNG NEOPLASM MALIGNANT 38 0.0009
907 IRRITABILITY 55 0.0009
908 NEUROTOXICITY 16 0.0009
909 DEVICE ADHESION ISSUE 14 0.0009
910 INJECTION SITE PRURITUS 61 0.0009
911 RESPIRATORY DISTRESS 25 0.0009
912 NEOPLASM MALIGNANT 60 0.0009
913 PLASMA CELL MYELOMA 35 0.0009
914 PROTEINURIA 17 0.0009
915 BONE DENSITY DECREASED 28 0.0009
916 INTENTIONAL SELF-INJURY 18 0.0009
917 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30 0.0009
918 CHOLESTASIS 17 0.0009
919 PRODUCT USE IN UNAPPROVED INDICATION 219 0.0009
920 VAGINAL HAEMORRHAGE 38 0.0009
921 SEPTIC SHOCK 38 0.0009
922 MULTI-ORGAN FAILURE 15 0.0009
923 CONJUNCTIVITIS 16 0.0009
924 PHARMACEUTICAL PRODUCT COMPLAINT 22 0.0008
925 INTENTIONAL OVERDOSE 54 0.0008
926 EXTRA DOSE ADMINISTERED 34 0.0008
927 NEUTROPHIL COUNT DECREASED 34 0.0008
928 TYPE 2 DIABETES MELLITUS 28 0.0008
929 INJECTION SITE ERYTHEMA 103 0.0008
930 C-REACTIVE PROTEIN INCREASED 30 0.0008
931 HAEMORRHAGE 86 0.0008
932 DEATH 707 0.0008
933 ANAPHYLACTIC SHOCK 21 0.0008
934 ANAPHYLACTIC REACTION 45 0.0008
935 OSTEONECROSIS OF JAW 20 0.0008
936 PNEUMONITIS 22 0.0008
937 DEVICE DISLOCATION 35 0.0008
938 OVERDOSE 173 0.0008
939 HYPERGLYCAEMIA 29 0.0008
940 LACRIMATION INCREASED 24 0.0008
941 DEVICE MALFUNCTION 55 0.0008
942 LEUKOPENIA 39 0.0008
943 INJECTION SITE URTICARIA 19 0.0008
944 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 18 0.0008
945 INJECTION SITE BRUISING 61 0.0008
946 ARRHYTHMIA 36 0.0008
947 INJECTION SITE HAEMORRHAGE 60 0.0008
948 NEUTROPENIA 102 0.0007
949 CARDIOVASCULAR DISORDER 19 0.0007
950 HEPATIC FAILURE 22 0.0007
951 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
952 DEVICE BREAKAGE 29 0.0007
953 BLOOD BILIRUBIN INCREASED 19 0.0007
954 PALLOR 19 0.0007
955 CYTOKINE RELEASE SYNDROME 14 0.0007
956 INJECTION SITE PAIN 213 0.0007
957 INJECTION SITE RASH 21 0.0007
958 INJECTION SITE SWELLING 52 0.0007
959 RHABDOMYOLYSIS 28 0.0007
960 OSTEONECROSIS 22 0.0007
961 ECZEMA 35 0.0007
962 DIABETIC KETOACIDOSIS 16 0.0007
963 SUICIDE ATTEMPT 39 0.0006
964 ACNE 48 0.0006
965 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 29 0.0006
966 PANCREATITIS 32 0.0006
967 THROMBOCYTOPENIA 67 0.0006
968 BREAST CANCER FEMALE 16 0.0006
969 MALIGNANT NEOPLASM PROGRESSION 61 0.0006
970 LIVER DISORDER 26 0.0006
971 METABOLIC ACIDOSIS 18 0.0006
972 BREAST CANCER 51 0.0005
973 ASCITES 15 0.0005
974 DRUG-INDUCED LIVER INJURY 16 0.0005
975 MATERNAL EXPOSURE DURING PREGNANCY 45 0.0005
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 18 0.0005
977 NEOPLASM PROGRESSION 17 0.0005
978 GYNAECOMASTIA 15 0.0005
979 SYSTEMIC LUPUS ERYTHEMATOSUS 17 0.0005
980 DERMATITIS ATOPIC 25 0.0005
981 FOETAL EXPOSURE DURING PREGNANCY 38 0.0005
982 DEVICE LEAKAGE 20 0.0005
983 PROSTATE CANCER 36 0.0004
984 DRUG WITHDRAWAL SYNDROME 38 0.0004
985 DRUG ABUSE 36 0.0004
986 NO ADVERSE EVENT 78 0.0004
987 PRODUCT STORAGE ERROR 35 0.0004
988 ABORTION SPONTANEOUS 16 0.0004
989 EXPOSURE DURING PREGNANCY 22 0.0004
990 BLADDER CANCER 19 0.0003
991 DRUG DEPENDENCE 41 0.0003
992 ACCIDENTAL EXPOSURE TO PRODUCT 25 0.0002
993 DRUG DOSE OMISSION BY DEVICE 18 0.0002